Neuronetics (NASDAQ: STIM) reported Q1 EPS of ($0.38), $0.04 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $16.71 million.

GUIDANCE:

Neuronetics sees FY2023 revenue of $68-73 million, versus the consensus of $68.7 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.